ABCC1 and osteosarcoma: Fendrr enhances doxorubicin resistance in doxorubicin-resistant and-sensitive human osteosarcoma cells by negatively regulating the post-transcriptional expression of the multidrug resistance-related proteins ABCB1 and ABCC1 [24].